LEQEMBI(R) Pen (Subcutaneous Formulation of LEQEMBI(R)) Now Available in Japan for Patients with Early Alzheimer's Disease
Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that "LEQEMBI(R) Pen", the subcutaneous (SC) formulation of "LEQEMBI(R)" (generic name: lecanemab) has been launched in Japan.